Viewing Study NCT00369434


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2026-02-08 @ 10:31 PM
Study NCT ID: NCT00369434
Status: COMPLETED
Last Update Posted: 2007-06-01
First Post: 2006-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Menopause View
None Vasomotor System View
Keywords: